Sign up
Log in
HeartSciences issues 425,000 restricted shares to CEO Simpson in unregistered sale
Share
Listen to the news
HeartSciences issues 425,000 restricted shares to CEO Simpson in unregistered sale
  • HeartSciences granted 425,000 restricted shares to CEO Andrew Simpson in an unregistered issuance exempt under Securities Act Section 4(a)(2) or Rule 506(b).
  • Shares were issued June 22, 2026, as a retention bonus tied to a proposed merger with Fortitude Mining HoldCo.
  • Stock is non-voting until vesting, with vesting contingent on closing-related conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-072722), on June 26, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.